Tessa Therapeutics

Tessa Therapeutics dissolves after raising more than $200M
Fierce Biotech
Thu, 07/6/23 - 09:59 pm
Tessa Therapeutics
cell therapy
Tessa Therapeutics’ ‘Off-the-Shelf’ CAR-T Therapy Shows Promising Results in Early-Stage Study of Hodgkin Lymphoma
BioSpace
Fri, 06/16/23 - 09:46 am
Tessa Therapeutics
CAR-T
Hodgkin's lymphoma
TT11X
Flush with $126M raise, Tessa Therapeutics woos new CEO from Takeda
Endpoints
Mon, 08/22/22 - 10:04 am
Tessa Therapeutics
Takeda
Thomas Willemsen
CAR-T
Pharma CEOs
The retrenchment begins for venture funding
EP Vantage
Fri, 07/8/22 - 10:36 am
funding
venture capital
Upstream Bio
Frontera Therapeutics
Aspen Neuro
Tessa Therapeutics
ReCode Therapeutics
Tessa Therapeutics takes in $126M for cell therapies, and more biotech financings
MedCity News
Mon, 06/13/22 - 10:39 am
Tessa Therapeutics
funding
Charm Therapeutics
Code Biotherapeutics
Mineralys
Synklino
Coya Therapeutics
Anagenex
DegronTherapeutics
Tessa Therapeutics to build commercial-scale facility for VST therapies
Fierce Pharma
Fri, 12/20/19 - 08:09 pm
Tessa Therapeutics
Singapore
drug manufacturing
cell therapy
Tessa Therapeutics Forges $120 Million Joint Venture to Develop Cell Therapies in China
BioSpace
Thu, 06/13/19 - 09:55 pm
Tessa Therapeutics
cell therapy
cancer
China-Singapore Guangzhou Knowledge City
China
Tessa showcases preclinical promise of 'all-in-one' add-on to its cancer cell therapy, in march to the clinic
Endpoints
Fri, 05/3/19 - 10:22 am
Tessa Therapeutics
CAR-T
virally-associated tumors
cancer
cell therapy